Intradermal testing has been used in the diagnosis of acute anaphylactic reactions during anaesthesia in 51 patients.
INTRODUCTION
The incidence of acute anaphylaxis during anaesthesia is increasing (Dundee 1976) .
When an anaphylactic reaction occurs during anaesthesia it is imperative that the patient does not receive the drug again; to prevent subsequent exposure the drug responsible must be determined.
In many of the anaesthetic reactions reported the reaction has been attributed to a drug on the basis of previous exposure alone, or the opinion of the anaesthetist; this can lead to subsequent fatal reactions. Where more than one drug is given it is not possible to determine by guesswork which drug is responsible, and severe reactions may occur without previous exposure by both anaphylactic and anaphylactoid mechanisms (Fisher 1978 ).
In 1976 we described the use of intradermal testing in the diagnosis of anaphylaxis during anaesthesia (Fisher 1976 ) and a modified protocol was suggested in 1977 (Fisher 1977 
Patient
Selection. All patients who were referred to the author with a diagnosis of a reaction during anaesthesia were tested. The only criteria was whether the anaesthetist felt that the patient's life was threatened by the reaction. In a number of cases the diagnosis of anaphylaxis could be excluded from the history but such patients were tested. Testing. The method used was that described in 1976 (Fisher 1976) for the first thirteen patients. After testing thirteen patients it became apparent that minor modifications must be used and these were described in 1977 (Fisher 1977) . The protocol used in the last 38 patients is as described below. The protocol was designed to minimise the inherent errors in intradermal testing as discussed in the original paper. 1.100,000 d-Tubocurarine should also be tested in greater dilution as a small number of false positives may occur due to direct histamine release. If a positive reaction occurs due to two drugs, serial dilutions are used. These dilutions are used to make the test simple, and have been experimentally determined in volunteers as being unlikely to cause false positives due to direct histamine release. 6. 0.1 ml is injected into the anterior surface of the forearm of patients and controls. 7. A positive result is a weal of greater than 1 cm which arises within ten minutes and persists for at least 30 minutes. 8. Confirmation. In a number of patients confirmation of the results has been possible. The result is regarded as confirmed when the drug used was the sole agent, antibodies to the drug have been demonstrated by other means, or the patient has had all the other drugs used when the reaction occurred, at a subsequent uneventful anaesthetic.
In the case of negative reactions the result has been confirmed by glVlng the patient the same anaesthetic on a subsequent occasion. 
RESULTS

DISCUSSION
The need to determine the nature of the reaction during anaesthesia and the drug responsible is beyond dispute. Various workers have used different tests.
Direct challenge has been used but is dangerous (Barjenbruch and Jones 1962, Fisher 1978) . Leucocyte challenge tests (Dundee et al. 1974 ) and basophil degranulation tests (Fox, Wilson and Rabow 1971) have been used but require special expertise and may also be susceptible to error due to direct histamine release. Changes in serum complement have been used to identify the nature of the reaction Thornton 1976) but these changes give no help as to the drug responsible.
Prick tests were tried but found unreliable (Lorenz et al. 1972) .
The advantages of intradermal testing are in its cost, ease of interpretation, performance and safety. Of the 51 patients tested three had symptoms from the testing. One patiel:1t developed tightness in the chest and tachyca~dla which responded immediately to adrenalme. A second patient felt faint and responded to lying down. A third patient complained of severe itching in the positive site which was eased by topical hydrocortisone.
There were some difficulties in interpretation. Two patients who had anaphylactic reactions to alfathesin (which was the sole agent) had a large flare reaction only. As this was absent from controls it was regarded as positive. This result has been described by others (Boy tell 1976).
One patient who had a reaction clinically suggestive of anaphylaxis with thiopentone as the sole agent showed a negative intradermal response. This patient may have had a non allergic reaction as there were no complement changes or complement conversion demonstrated.
One patient who .h~d a definite clini~al reaction to propamdld and a negatIve intradermal test was taking prednisone for asthma, and as propanidid was the sole agent used and she was a severe asthmatic it was felt unjustified to stop the steroids for testing purposes.
One patient had a negative test to alfathesin 18 months after a clinical reaction. Turner, Keep and Bartholomaus (1972) de~c.ribed. a patient who had originally had a poslt.lve skm reaction to propanidid which was negatIve after 22 months. Two patients in this series nau positive tests to alfathesin at six weeks and negative tests at two years.
Four out of four patients tested with positive tests to muscle relaxants had equally positive tests at two years.
The other difficulty that occurred was in two patients with positive reactions to alcuronium and d-tubocurarine. In one of these, several dilutions showed alcuronium to be the cause, and in the other serial dilutions were not performed. The patients were both warned about both drugs.
Although intradermal testing has been suggested as "hazardous", and recently described as "notoriously unreliable in such circumstances" (Baxter 1978 , Walton 1978 we feel that this paper confirms the editorial suggestion of 1976, that it is the very least that should be done (Editorial 1976) .
The deficiencies of intradermal testing were discussed in our initial paper (Fisher 1976) and the protocol designed to minimize these. Further, the anaesthetic situation removes a number of other objections which have been raised to intradermal testing in general: there is a ready source of pure antigen, a limited number of possibilities and a highly sensitive patient.
There was only one patient in this series (who had a reaction, which was probably clinical anaphylaxis after six drugs) in whom a combination of history and intradermal testing did not give the diagnosis.
However the test appears useless with colloid solutions and local anaesthetics which has been demonstrated by other workers (Hedin and Richter 1977 , Lund 1976 , I ncaudo et al. 1978 .
The successful use of this test has now been described by a number of other workers (Matthews, Ceglarsky and Pabari 1977 , Evans and McKinnon 1977 , McKie 1978 . In addition the author has received 12 personal communications of successful tests.
Intradermal testing is not adequate alone. It is imperative that the patient be warned of the nature of the reaction in detail, and appropriate safeguards such as bracelets or chains with a warning are necessary.
If there is any doubt about the nature of the reaction the patient should be pretreated. Prednisone 5 mg three times daily for three days and a large dose of antihistamine with the premedication will prevent reactions to contrast media (Kelly et al. 1978) and may well prevent anaesthetic reactions.
In one case (Lorenz et al. 1972) it was demonstrated that a large dose of methyl prednisolone and an antihistamine prevented anaphylaxis in a patient allergic to propanidid. Lorenz and Doenicke (1978) have shown that an HI and H2 antihistamine will prevent reactions to Haemaccel but this would not be adequate in other circumstances as other mediators are involved.
Disodium chromoglycate has also been advocated as theoretically likely to prevent reactions (Clarke 1977) . If the patient is at extreme risk pretreatment with adrenaline should be considered in addition as it is known to prevent histamine release, and is believed to have reduced mortality due to anaphylaxis from antivenoms (Sutherland 1977) .
